Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aarey Drugs & Pharmaceuticals Ltd

₹ 70.7 -0.76%
17 Sep - close price
aareydrugs.com BSE: 524412 NSE: AAREYDRUGS
About

Incorporated in 1990, Aarey Drugs & Pharmaceuticals Ltd is a manufacturer of API / Bulk Drugs and offers products for diverse
industrial applications[1]

Key Points

Business Overview:[1]
ADPL does manufacturing of active pharmaceutical ingredients, intermediates, specialty chemicals, and trading of industrial solvents & chemicals. It caters to pharmaceuticals formulation manufacturers and pharmaceutical merchant exports.

Website BSE NSE - BE
  • Market Cap ₹ 197 Cr.
  • Current Price ₹ 70.7
  • High / Low ₹ 75.7 / 31.3
  • Stock P/E 47.4
  • Book Value ₹ 48.8
  • Dividend Yield 0.00 %
  • ROCE 6.38 %
  • ROE 2.96 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Debtor days have improved from 146 to 103 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 9.76% over past five years.
  • Company has a low return on equity of 3.31% over last 3 years.
  • Earnings include an other income of Rs.9.79 Cr.
  • Promoter holding has decreased over last 3 years: -5.23%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
118.84 76.26 62.47 162.88 50.96 57.83 76.48 210.35 126.91 105.14 133.79 108.10 102.21
117.93 71.99 60.94 160.36 49.62 55.99 73.78 211.79 125.73 101.42 131.59 112.31 100.50
Operating Profit 0.91 4.27 1.53 2.52 1.34 1.84 2.70 -1.44 1.18 3.72 2.20 -4.21 1.71
OPM % 0.77% 5.60% 2.45% 1.55% 2.63% 3.18% 3.53% -0.68% 0.93% 3.54% 1.64% -3.89% 1.67%
0.85 -0.94 0.48 0.84 0.70 0.84 0.29 5.14 1.58 0.02 0.68 7.54 1.55
Interest 0.55 0.59 0.71 0.20 0.42 0.41 0.47 0.40 0.96 0.49 0.58 1.30 1.04
Depreciation 0.41 0.42 0.55 1.02 0.89 1.27 1.06 1.15 0.47 1.51 0.90 0.41 0.49
Profit before tax 0.80 2.32 0.75 2.14 0.73 1.00 1.46 2.15 1.33 1.74 1.40 1.62 1.73
Tax % 0.00% 9.05% -33.33% 83.18% 0.00% -22.00% 30.14% -0.47% 6.77% 8.62% 48.57% 71.60% 20.81%
0.80 2.12 1.00 0.36 0.72 1.23 1.02 2.15 1.24 1.60 0.72 0.47 1.37
EPS in Rs 0.32 0.84 0.39 0.14 0.28 0.48 0.40 0.77 0.44 0.57 0.25 0.17 0.48
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
200 213 246 396 349 354 298 348 493 419 396 474 449
198 212 245 386 342 347 294 344 481 411 391 471 446
Operating Profit 1 1 1 10 8 8 3 5 11 8 4 3 3
OPM % 1% 1% 0% 2% 2% 2% 1% 1% 2% 2% 1% 1% 1%
2 3 3 3 3 4 7 7 3 3 7 10 10
Interest 1 1 2 4 2 2 2 2 2 3 4 5 3
Depreciation 1 1 1 1 1 1 1 1 2 2 2 2 3
Profit before tax 1 1 2 8 8 9 7 8 10 6 5 6 6
Tax % 22% 23% 29% 31% 25% 27% 20% 21% 35% 37% 12% 34%
1 1 1 5 6 7 6 7 7 4 5 4 4
EPS in Rs 0.62 0.65 0.77 3.02 2.64 2.80 2.48 2.78 2.58 1.49 1.67 1.42 1.47
Dividend Payout % 0% 0% 0% 0% 0% 4% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 8%
5 Years: 10%
3 Years: -1%
TTM: -5%
Compounded Profit Growth
10 Years: 14%
5 Years: -7%
3 Years: -15%
TTM: -26%
Stock Price CAGR
10 Years: 18%
5 Years: 19%
3 Years: 19%
1 Year: 2%
Return on Equity
10 Years: 6%
5 Years: 4%
3 Years: 3%
Last Year: 3%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 17 17 17 18 23 23 23 23 25 25 28 28
Reserves 18 19 20 31 57 63 69 75 88 92 105 110
6 11 15 10 3 16 18 18 14 38 31 35
67 69 74 83 86 43 84 116 117 136 139 117
Total Liabilities 107 115 125 142 170 146 194 233 245 291 303 291
4 6 8 12 12 12 12 14 14 14 13 16
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 1 2
102 109 117 130 157 133 181 218 230 277 289 272
Total Assets 107 115 125 142 170 146 194 233 245 291 303 291

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0 3 6 1 -20 1 3 5 0 -1 -3 10
2 -2 -3 -5 -1 -1 -1 -3 -3 0 -2 -6
-1 -2 -2 4 23 -2 -2 -2 2 1 6 -4
Net Cash Flow 0 -1 1 -1 2 -3 0 0 -0 1 1 -0

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 119 114 108 75 100 109 118 170 101 165 170 103
Inventory Days 10 7 3 5 16 23 21 20 11 26 33 36
Days Payable 119 117 108 71 84 40 98 120 86 115 123 81
Cash Conversion Cycle 9 5 3 9 32 92 42 69 26 76 80 58
Working Capital Days 52 49 40 34 69 77 99 91 68 89 106 89
ROCE % 6% 7% 7% 22% 14% 12% 8% 9% 10% 6% 6% 6%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
50.04% 50.04% 50.05% 50.04% 50.04% 50.04% 45.28% 45.28% 45.44% 44.80% 44.80% 44.80%
3.98% 3.92% 3.92% 3.92% 3.94% 3.83% 3.40% 3.40% 2.75% 2.34% 2.34% 1.97%
45.97% 46.04% 46.04% 46.03% 46.01% 46.12% 51.31% 51.32% 51.81% 52.86% 52.86% 53.23%
No. of Shareholders 17,64917,78517,69917,53816,08615,26916,84316,17916,67616,28816,25715,796

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings